GSA CAPITAL PARTNERS LLP - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$75,000
-3.8%
64,786
+59.6%
0.01%0.0%
Q1 2019$78,000
+27.9%
40,600
+53.2%
0.01%
+14.3%
Q4 2018$61,000–26,500–0.01%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q1 2019
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders